GASTFOX: Evaluate FOLFOX With or Without Docetaxel (TFOX) as First-Line Chemotherapy for Locally Advanced or Metastatic Esophago-Gastric Carcinoma

Commentary
Video

Rachna Shroff, MD, details key data from the phase III GASTFOX study comparing FOLFOX to docetaxel (TFOX) in the first line treatment of advanced gastric cancer.

Related Videos
Experts on GI cancer
Experts on GI cancer
Experts on CRC
Experts on GI Cancer
Experts on GI cancer
Experts on GI cancer
Related Content